Your browser doesn't support javascript.
loading
A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study.
Tan, Lavinia; Tran, Ben; Tie, Jeanne; Markman, Ben; Ananda, Sumi; Tebbutt, Niall C; Michael, Michael; Link, Emma; Wong, Stephen Q; Chandrashekar, Sushma; Guinto, Jerick; Ritchie, David; Koldej, Rachel; Solomon, Benjamin J; McArthur, Grant A; Hicks, Rodney J; Gibbs, Peter; Dawson, Sarah-Jane; Desai, Jayesh.
Afiliación
  • Tan L; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Tran B; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
  • Tie J; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Markman B; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
  • Ananda S; Division of Personalized Oncology, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Tebbutt NC; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Michael M; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
  • Link E; Division of Personalized Oncology, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Wong SQ; Monash Health, Melbourne, Victoria, Australia.
  • Chandrashekar S; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Guinto J; Olivia Newton John Cancer Wellness and Research Centre, Melbourne, Victoria, Australia.
  • Ritchie D; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Koldej R; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
  • Solomon BJ; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • McArthur GA; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
  • Hicks RJ; Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Gibbs P; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Dawson SJ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
  • Desai J; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Clin Cancer Res ; 29(6): 1017-1030, 2023 03 14.
Article en En | MEDLINE | ID: mdl-36638198
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias del Recto / Neoplasias Colorrectales / Neoplasias del Colon Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias del Recto / Neoplasias Colorrectales / Neoplasias del Colon Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos